Jonna M. Frasor, Ph.D.
Affiliations: | 2001 | University of Illinois at Chicago, Health Sciences Center, Chicago, IL 60612, United States |
Area:
Animal Physiology Biology, Molecular BiologyGoogle:
"Jonna Frasor"Parents
Sign in to add mentor| Geula Gibori | grad student | 2001 | University of Illinois at Chicago, Health Sciences Center | |
| (Prolactin signaling in the regulation of estrogen receptor gene expression.) | ||||
| Benita S. Katzenellenbogen | post-doc | UIUC (Chemistry Tree) | ||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Santaliz-Casiano A, Mehta D, Danciu OC, et al. (2023) Identification of metabolic pathways contributing to ER breast cancer disparities using a machine-learning pipeline. Scientific Reports. 13: 12136 |
| Semina SE, Alejo LH, Chopra S, et al. (2022) Identification of a novel ER-NFĸB-driven stem-like cell population associated with relapse of ER+ breast tumors. Breast Cancer Research : Bcr. 24: 88 |
| Pal P, Atilla-Gokcumen GE, Frasor J. (2022) Emerging Roles of Ceramides in Breast Cancer Biology and Therapy. International Journal of Molecular Sciences. 23 |
| Smart E, Semina SE, Alejo LH, et al. (2022) Estrogen Receptor-Regulated Gene Signatures in Invasive Breast Cancer Cells and Aggressive Breast Tumors. Cancers. 14 |
| Pal P, Millner A, Semina SE, et al. (2022) Endocrine Therapy-Resistant Breast Cancer Cells Are More Sensitive to Ceramide Kinase Inhibition and Elevated Ceramide Levels Than Therapy-Sensitive Breast Cancer Cells. Cancers. 14 |
| Semina SE, Pal P, Kansara NS, et al. (2022) Selective pressure of endocrine therapy activates the integrated stress response through NFκB signaling in a subpopulation of ER positive breast cancer cells. Breast Cancer Research : Bcr. 24: 19 |
| Smart E, Semina SE, Frasor J. (2020) Update on the role of NFκB in promoting aggressive phenotypes of estrogen receptor (ER) positive breast cancer. Endocrinology. 161 |
| Hases L, Indukuri R, Birgersson M, et al. (2020) Intestinal estrogen receptor beta suppresses colon inflammation and tumorigenesis in both sexes. Cancer Letters |
| Kastrati I, Joosten SEP, Semina SE, et al. (2020) The NFκB pathway promotes tamoxifen tolerance and disease recurrence in estrogen receptor positive breast cancers. Molecular Cancer Research : McR |
| Smart E, Alejo LH, Frasor J. (2020) Cytoplasmic ERα and NFκB Promote Cell Survival in Mouse Mammary Cancer Cell Lines. Hormones and Cancer. 11: 76-86 |